Difficulty: Medium
Average Score: 85%
Practice
One of the following metabolic abnormalities may be associated with tumor lysis syndrome:
Correct answer
B
Rationale
In the context of pediatric oncology, tumor lysis syndrome (TLS) is a critical concern when treating patients with rapidly proliferating tumors. TLS is characterized by metabolic abnormalities resulting from the massive release of intracellular contents into the bloodstream following cancer treatment, particularly in response to chemotherapy. Hyperkalemia (Option B) is a classic feature of TLS due to the release of potassium from lysed cells.
Hypernatremia (Option A) and hyponatremia (Option D) are not typically associated with TLS. Hypernatremia is more commonly seen in conditions like dehydration or diabetes insipidus, while hyponatremia can be caused by conditions like fluid overload or syndrome of inappropriate antidiuretic hormone (SIADH).
Hypokalemia (Option C) is also not a characteristic finding in TLS. It is more commonly seen in conditions like diuretic use, gastrointestinal losses, or renal tubular disorders.
In an educational context, understanding the metabolic abnormalities associated with TLS is crucial for pediatric nurses caring for oncology patients. Recognizing the signs and symptoms of TLS, including hyperkalemia, allows nurses to intervene promptly to prevent life-threatening complications. This knowledge also underscores the importance of close monitoring and early intervention in pediatric oncology settings to provide safe and effective care to vulnerable patients.
Hypernatremia (Option A) and hyponatremia (Option D) are not typically associated with TLS. Hypernatremia is more commonly seen in conditions like dehydration or diabetes insipidus, while hyponatremia can be caused by conditions like fluid overload or syndrome of inappropriate antidiuretic hormone (SIADH).
Hypokalemia (Option C) is also not a characteristic finding in TLS. It is more commonly seen in conditions like diuretic use, gastrointestinal losses, or renal tubular disorders.
In an educational context, understanding the metabolic abnormalities associated with TLS is crucial for pediatric nurses caring for oncology patients. Recognizing the signs and symptoms of TLS, including hyperkalemia, allows nurses to intervene promptly to prevent life-threatening complications. This knowledge also underscores the importance of close monitoring and early intervention in pediatric oncology settings to provide safe and effective care to vulnerable patients.